XTalks

MARCH 6, 2023

The portfolio contains approximately forty-five commercial products, four products in the pipeline, and forty approved non-marketed products, many of which are generics focused on women’s health. The company offers numerous products including generics, branded generics, biosimilars and over-the-counter products.

Production 98

Production Branding Dermatology Hormones 98

XTalks

JULY 16, 2021

Johnson & Johnson is recalling sunscreens from two of its popular brands over concerns of carcinogenic benzene contamination. Related: Google Launches AI-Based Dermatology Assist Tool. In a news release , J&J said it is exercising “an abundance of caution” by pulling its Neutrogena and Aveeno spray sunscreens from shelves.

Contamination 105

Contamination Production Drugs Branding 105

Olympian Clinical Research

FEBRUARY 13, 2024

At Academic Alliance in Dermatology, we understand the importance of using products that not only care for your skin on the surface but also work effectively at a cellular level. This is where medical-grade skincare like SkinCeuticals, ZO, Colorescience, Obagi, SkinMedica and Alastin distinctly outshine drugstore brands.

Production 52

Production Dermatology Branding Containment 52

Druggist

DECEMBER 9, 2020

Lotions: contain the least amount of oils and higher amounts of water with non-greasy consistency. Clobetasone (brand name: Eumovate cream). Clobetasone (brand name: Eumovate) is the second steroid cream on the list, which is available over the counter. Eurax cream contains 10% crotamiton. Daktacort cream. £5.00.

Pharmacy 97

Pharmacy Containment Sales Production 97

The Pharma Data

NOVEMBER 4, 2020

TSX: CTX) (OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house research & development (“R&D”) and manufacturing capabilities, today announced that it has entered into an exclusive agreement with Juyou-Biotechnology Co.

Licensing 40

Licensing Licensing Dermatology Production 40

The Pharma Data

MAY 18, 2021

The performance remained ahead of competition with growth momentum in the Dermatology and Nutritionals categories, with business up by 6.6 percent, largely on account of lower marketing expenses in the currently volatile market environment as well as one-time gains from the divestment of three non-core brands. percent and 4.7

Sales 40

Sales Production Marketing Containment 40

The Pharma Data

DECEMBER 15, 2020

Klisyri is the first FDA approved branded proprietary product for Athenex and will be launched in partnership with Almirall in the U.S. We invest in differentiated and groundbreaking medical dermatology products to bring our innovative solutions to patients in need. during the first quarter of 2021.

FDA Approval 52

FDA Approval Development Production Drugs 52